Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Choriogonadotropin alfa
Drug ID BADD_D00457
Description Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.
Indications and Usage For the treatment of female infertility
Marketing Status approved
ATC Code G03GA08
DrugBank ID DB00097
KEGG ID D03478
MeSH ID D006063
PubChem ID Not Available
TTD Drug ID D00TTS
NDC Product Code 50090-5923; 0052-0315; 78206-150; 69443-315; 12860-0315; 44087-1150
UNII 6413W06WR3
Synonyms Chorionic Gonadotropin | Gonadotropin, Chorionic | Choriogonadotropin | Choriogonin | Pregnyl | Chorulon | Gonabion | Biogonadil | Chorionic Gonadotropin, Human | Gonadotropin, Human Chorionic | Human Chorionic Gonadotropin | HCG (Human Chorionic Gonadotropin)
Chemical Information
Molecular Formula Not Available
CAS Registry Number 177073-44-8
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Multiple congenital abnormalities03.02.01.003---
Mycoplasmal postpartum fever11.10.01.001; 21.14.04.002---
Nausea07.01.07.001--
Ovarian cyst16.04.03.001; 21.11.01.002---
Ovarian enlargement21.11.02.001---
Ovarian hyperstimulation syndrome05.05.01.013; 21.11.02.007---
Pain08.01.08.004--
Paraesthesia17.02.06.005; 23.03.03.094--
Pharyngitis07.05.07.004; 11.01.13.003; 22.07.03.004--
Premature labour18.07.01.002---
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rash23.03.13.001---
Thrombocytopenia01.08.01.002---
Upper respiratory tract infection11.01.13.009; 22.07.03.011--
Urinary incontinence17.05.01.008; 20.02.02.010--
Urinary tract infection11.01.14.004; 20.08.02.001--
Uterine disorder21.07.01.006---
Vaginal discharge21.08.02.002--
Vaginal haemorrhage21.08.01.001; 24.07.03.005--
Vaginal infection11.01.10.002; 21.14.02.002--
Vomiting07.01.07.003--
Vulvovaginal discomfort21.08.02.005---
Affect lability19.04.01.001---
Hot flush08.01.03.027; 21.02.02.001; 24.03.01.005--
Pulmonary vascular disorder22.06.03.002; 24.03.08.003---
Ovarian neoplasm16.12.06.001; 21.11.01.005---
Procedural pain08.01.08.009; 12.02.05.007---
Adnexal torsion21.11.02.012---
Haemoperitoneum07.07.02.007; 12.01.17.007; 24.07.02.065---
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages